V relevant given newly-finalized guidance from FDA Oncology, these are potentially actionable changes in trial eligibility criteria to address age disparities. Highlighted in Science Magazine science.org/content/articl…. Excellent work by Roshal Patel & co! @cd_fuller Noam VanderWalde

Amazing work Bea Fregonese presenting our initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke

#ICML2025 Brandon Imber

Double trouble! Congrats to Rosh on his important work showing that bridging RT prior to CAR T cells is safe and probably needs greater personalization by tumor genetics. Great work! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center #18ICML

Beyond proud of our Memorial Sloan Kettering Radiation Oncology hematology research team! Exciting research at the forefront of all aspects of #18ICML!! Hopefully the Lago view makes up for all the hard work 😉 Memorial Sloan Kettering Cancer Center